. Author manuscript; available in PMC: 2017 Aug 1.

Published in final edited form as: Ann Surg Oncol. 2016 May 24;23(8):2438–2445. doi: 10.1245/s10434-016-5275-3

TABLE 3.

Factors associated with successful ablation (central review residual disease information)

	Successful ablation (n = 80)	Unsuccessful ablation (n = 7)	p-Value
MRI status			0.37
Residual enhancement	20 (87.0)	3 (13.0)
No residual enhancement	60 (93.8)	4 (6.2)
HR status			0.99
Negative	4 (100.0)	0
Positive	76 (91.6)	7 (8.4)
Tumor grade			0.38
Low	29 (96.7)	1 (3.3)
Intermediate	31 (88.6)	4 (11.4)
High	12 (85.7)	2 (14.3)
Tumor size, cm			0.34
<1.0	16 (100.0)	0
≥1.0	64 (90.1)	7 (9.9)
MRI status for tumor size <1.0
Residual enhancement	5 (100.0)	0
No residual enhancement	11 (100.0)	0
MRI status for tumor size ≥1.0			0.36
Residual enhancement	15 (83.3)	3 (16.7)
No residual enhancement	49 (92.4)	4 (7.6)

	Successful ablation or MRI residual disease	Unsuccessful ablation and MRI no residual disease

Tumor size, cm			0.99
<1.0	16 (100.0)	0
≥1.0	67 (94.4)	4 (5.6)